Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089572

« Back to Dashboard

NDA 089572 describes PYRIDOSTIGMINE BROMIDE, which is a drug marketed by Alvogen Malta, Impax Labs Inc, Kinedexe Uk, Ani Pharms Inc, Impax Labs, Solvay, Us Army, and Zydus Pharms Usa Inc, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the PYRIDOSTIGMINE BROMIDE profile page.

The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.

Summary for 089572

Tradename:	PYRIDOSTIGMINE BROMIDE
Applicant:	Solvay
Ingredient:	pyridostigmine bromide
Patents:	0
Therapeutic Class:	Antimyasthenic Agents
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 089572

Cholinesterase Inhibitors

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	30MG
Approval Date:	Nov 27, 1990	TE:		RLD:	No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb

Queensland Health

Fish and Richardson

Baxter

Teva

Cantor Fitzgerald

Federal Trade Commission

Argus Health

UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.